Understanding genetics in focal epilepsy brain tissue
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study is looking at brain tissue from people with a specific type of epilepsy (Focal Cortical Dysplasia Type II). The goal is to understand what causes the seizures and how they develop, which may help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of Focal Cortical Dysplasia Type IIA or IIB (either confirmed by a biopsy or strongly suspected from MRI and other scans).
- You are scheduled to receive epilepsy surgery to remove the affected brain area.
- You can attend appointments to give a blood sample and a nasal swab.
- You are able to provide written informed consent (or a parent/guardian can for you).
- No other medical condition that would make it hard to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at ways to diagnose and treat focal epilepsy that isn't controlled by medications. It includes patients with or without a visible brain lesion on imaging.
This study uses MRI and a special EEG to understand brain connections in people with specific types of epilepsy or genetic conditions like Angelman syndrome and Dup15q. It may help find better ways to treat these conditions.
This study tests how well a specific brain-recording device works during a procedure used to map seizure origins in people with drug-resistant, disabling focal epilepsy. It may help doctors plan treatment by improving how well they can localize the seizure focus before possible surgery.
This study looks at how epilepsy affects a brain chemical that helps control breathing and alertness. It uses a special scan to see this chemical, which may help find better treatments for seizures.
This study is observing how the brain's connections and activity work in people with epilepsy. It uses MRI scans and EEG recordings to learn more about the condition, which may help improve future treatments.
This Phase 2 trial tests SPN-817 in adults whose seizures are still not well controlled despite trying multiple seizure medicines. It targets people with a specific type of brain finding called focal cortical dysplasia and looks at safety/tolerability and seizure outcomes over several weeks.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.